Almanac Between Issues
September 2, 2010
An Announcement from President Amy Gutmann:
I am delighted to announce the selection of Dr. J. Larry Jameson as Executive Vice President of the University for the Health System and Dean of the School of Medicine, effective July 1, 2011. Dr. Jameson will join Penn from Northwestern University, where he has served since 2007 as Vice President for Medical Affairs and Lewis Landsberg Dean of the Feinberg School of Medicine.
As EVP/Dean, Dr. Jameson will be responsible for the oversight and strategic management of Penn Medicine, including the conduct, coordination, and quality of all of Penn Medicine’s academic programs, research activities, and clinical services. Ralph Muller, the CEO of the University of Pennsylvania Health System, will report to Dr. Jameson.
In selecting a new EVP/Dean, I sought an eminent academic and researcher with impeccable academic judgment, a deep appreciation for Penn Medicine’s exceptional clinical programs, an unwavering ethical compass, and a desire to broadly engage with the Penn community. Above all, I sought a strong leader with an unyielding commitment to eminence, the highest ambitions for the quality of Penn Medicine, and a demonstrated ability to collaborate across campus to propel forward our vision for Penn as articulated in the Penn Compact.
Dr. Jameson brings to Penn all of this and more. He has a sterling track record as a skilled and compassionate clinician, a dedicated teacher and mentor, a prolific researcher and writer, and a gifted leader and administrator with the utmost commitment to the productive interplay of research, education, and clinical practice through interdisciplinary collaborations and partnerships. I am confident that Dr. Jameson will excel in his new role and successfully partner with Penn Medicine’s faculty, students, and staff to lead our clinical, educational, and research programs to even greater heights of quality and prominence.
As Vice President and Dean at Northwestern, Dr. Jameson has focused on interdisciplinary research and clinical programs in ways that parallel our goals under the Penn Compact. As co-chair of the “One Northwestern” initiative, he has forged new ties between the Feinberg School of Medicine and Northwestern’s other 11 schools. He has created new interdisciplinary research and educational opportunities for faculty and students. He has worked closely with the leadership of Northwestern Memorial Hospital and the Northwestern Medical Faculty Foundation to forge new alliances, align academic and clinical goals, and jointly recruit academic, clinical, and administrative leadership.
Prior to his appointment as Vice President and Dean, Dr. Jameson was the Irving S. Cutter Professor of Medicine and chair of the Department of Medicine at Northwestern for seven years. He led initiatives that greatly increased research funding and clinical activity; he redesigned residency and physician-scientist training programs; and he developed new faculty mentoring and leadership programs. He began his tenure at Northwestern in 1993 as chief of the Division of Endocrinology, Metabolism, and Molecular Medicine. Earlier in his career, he was associate professor of medicine at the Harvard Medical School and chief of the Thyroid Unit at Massachusetts General Hospital.
An internationally recognized researcher, Dr. Jameson’s pioneering work in molecular endocrinology has greatly improved our understanding of the transcription of endocrine genes and the genetic basis of reproductive and metabolic disorders. Dr. Jameson’s work has helped bridge laboratory studies with clinical endocrinology, a vitally important experience as Penn Medicine prepares to open a new Translational Research Center adjacent to our Perelman Center for Advanced Medicine and Roberts Proton Therapy Center.
Dr. Jameson has authored more than 300 scientific articles and chapters, including studies that have been published in leading journals including the New England Journal of Medicine, Nature Genetics, Science, and the Journal of Clinical Investigation. He is an editor of Harrison’s Principles of Internal Medicine, the most widely used textbook in the field worldwide. He is co-author of DeGroot and Jameson’s Endocrinology, the most comprehensive text in endocrinology, now in its 6th edition; and he is author of the award-winning Jameson’s Principles of Molecular Medicine, which serves as a principal text in this interdisciplinary field, fostering the bedside clinical application of basic scientific research.
Among his professional distinctions and honors, Dr. Jameson was elected to the Institute of Medicine, the American Academy of Arts and Sciences, the American Society of Clinical Investigation, and the Association of American Physicians. He has served as president of the Endocrine Society, as a member of the medical advisory board of the Howard Hughes Medical Institute, as a director of the American Board of Internal Medicine, and as a member of the Jury for the Lasker Award. Dr. Jameson is the recipient of distinguished awards, including the Van Meter Award from the American Thyroid Association, the Thomas G. Sheen Award from the American College of Surgeons, and the Oppenheimer and Koch Awards from the Endocrine Society.
Dr. Jameson received his Doctor of Medicine degree with honors and a Ph.D. degree in biochemistry from the University of North Carolina in 1981. He received his clinical training in internal medicine at Massachusetts General Hospital in Boston.
As we welcome Dr. Jameson to Penn, I want to take this opportunity again to express my thanks and appreciation to Dr. Arthur Rubenstein for his exemplary ongoing service as EVP/Dean of Penn Medicine since 2001. The conclusion of Dr. Rubenstein’s second-term on June 30, 2011 will mark the culmination of ten extraordinarily successful and productive years that have immeasurably strengthened Penn Medicine’s faculty; dramatically expanded its teaching, research, clinical programs, and facilities; and stabilized and strengthened Penn Medicine’s financial position. As a result of Dr. Rubenstein’s strong and inclusive leadership and tireless commitment to excellence, Penn Medicine today is stronger, more eminent, and more interdisciplinary than at any point in its history. In short, Penn Medicine is indisputably among the very finest integrated academic medical centers in the world. We all look forward to building on this formidable base.
I also wish to thank the members of the Ad Hoc Consultative Committee and its chair, Provost Vincent Price, for so very ably advising me during this vitally important search. I thank each and every member of the Committee for their extreme diligence, hard work, and deep commitment to the future of Penn Medicine.
Please join me in warmly welcoming Dr. Larry Jameson to the Penn community!